Literature DB >> 24962617

Interleukin 10 gene promoter polymorphisms in women with early-onset pre-eclampsia.

S Sowmya1, K Sri Manjari, A Ramaiah, T Sunitha, P Nallari, A Jyothy, A Venkateshwari.   

Abstract

Pre-eclampsia is one of the most serious disorders of human pregnancy and T helper type 1 (Th1)/Th2 imbalance plays a major role in its aetiology. The Th2 cytokine, interleukin (IL)-10, plays a significant role in the maintenance of pregnancy. The present study is aimed at understanding the role of IL-10 promoter polymorphisms (-1082 G/A; -592 A/C and -819 C/T) and their haplotypes in early-onset pre-eclampsia. A total of 120 patients and an equal number of women with normal pregnancy, from Government Maternity Hospital, Petlaburz, Hyderabad, India, were considered for the present study. A standard amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) was carried out for genotyping followed by agarose gel electrophoresis. Appropriate statistical methods were applied to test for the significance of the results. It was found that the IL-10 -819 C allele (P = 0·003) and -592 A (P = 0·005) allele frequencies increased significantly in patients compared to controls. No significant difference was found with regard to -1082 promoter polymorphism. Haplotype analysis of the IL-10 single nucleotide polymorphisms (SNPs) revealed a significant association with ACC haplotype with a twofold increased risk in patients compared to controls. The frequencies of two common IL-10 haplotypes (GCC and ATA) did not show any significant difference. Further, the diplotype analysis revealed five genotypes: -1082A with -819C (P = 0·0016); -1082G with -819C (P = 0·0018); -819C with -592C (P = 0·001); -1082A with -592C (P = 0·032); and -1082G with -592C (P = 0·005) associated with the disease. These findings support the concept of contribution of IL-10 gene polymorphisms in the pathogenesis of early-onset pre-eclampsia.
© 2014 British Society for Immunology.

Entities:  

Keywords:  Th1/Th2; haplotype; interleukin-10; pre-eclampsia; reproductive immunology

Mesh:

Substances:

Year:  2014        PMID: 24962617      PMCID: PMC4233382          DOI: 10.1111/cei.12402

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  46 in total

1.  ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta 1 gene polymorphisms.

Authors:  C Perrey; S J Turner; V Pravica; W M Howell; I V Hutchinson
Journal:  Transpl Immunol       Date:  1999-06       Impact factor: 1.708

Review 2.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

3.  New polymorphisms in the IL-10 promoter region.

Authors:  S D'Alfonso; M Rampi; V Rolando; M Giordano; P Momigliano-Richiardi
Journal:  Genes Immun       Date:  2000-02       Impact factor: 2.676

4.  Increase in the production of interleukin-10 early after implantation is related to the success of pregnancy.

Authors:  M Y Wu; H F Chen; S U Chen; K H Chao; Y S Yang; H N Ho
Journal:  Am J Reprod Immunol       Date:  2001-12       Impact factor: 3.886

5.  The interleukin-10-1082 G/A polymorphism: allele frequency in different populations and functional significance.

Authors:  L E N Rees; N A P Wood; K M Gillespie; K N Lai; K Gaston; P W Mathieson
Journal:  Cell Mol Life Sci       Date:  2002-03       Impact factor: 9.261

6.  Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms.

Authors:  Ana Suárez; Patricia Castro; Rebeca Alonso; Lourdes Mozo; Carmen Gutiérrez
Journal:  Transplantation       Date:  2003-03-15       Impact factor: 4.939

7.  Analysis of the 5' flanking region of the interleukin 10 gene in patients with systemic sclerosis.

Authors:  A Crilly; J Hamilton; C J Clark; A Jardine; R Madhok
Journal:  Rheumatology (Oxford)       Date:  2003-07-16       Impact factor: 7.580

8.  Alleles carried at positions -819 and -592 of the IL10 promoter affect transcription following stimulation of peripheral blood cells with Streptococcus pneumoniae.

Authors:  Suzanna E L Temple; Esther Lim; Karey Y Cheong; Coral-Ann M Almeida; Patricia Price; Kristin G Ardlie; Grant W Waterer
Journal:  Immunogenetics       Date:  2003-11-06       Impact factor: 2.846

9.  Role of IL-10 -819(t/c) promoter polymorphism in preeclampsia.

Authors:  Sabnavis Sowmya; Aruna Ramaiah; Tella Sunitha; Pratibha Nallari; Akka Jyothy; Ananthapur Venkateshwari
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

Review 10.  Cytokine signaling/transcription factor cross-talk in T cell activation and Th1-Th2 differentiation.

Authors:  Ana C Liberman; Damian Refojo; Eduardo Arzt
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2003       Impact factor: 4.291

View more
  7 in total

Review 1.  Genetic, immune and vasoactive factors in the vascular dysfunction associated with hypertension in pregnancy.

Authors:  Sajjadh M J Ali; Raouf A Khalil
Journal:  Expert Opin Ther Targets       Date:  2015-08-17       Impact factor: 6.902

2.  Haplotype analysis of IL-10 gene polymorphism in couples with spontaneous abortions and aborted fetuses.

Authors:  M Vidyadhari; M Sujatha; P Krupa; Pratibha Nallari; A Venkateshwari
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

3.  Association between Interleukin-10 gene polymorphisms and risk of early-onset preeclampsia.

Authors:  Limeng Song; Mei Zhong
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 4.  The Role of Interleukin-10 in the Pathophysiology of Preeclampsia.

Authors:  Hajrunisa Cubro; Sonu Kashyap; Meryl C Nath; Allan W Ackerman; Vesna D Garovic
Journal:  Curr Hypertens Rep       Date:  2018-04-30       Impact factor: 5.369

5.  Association of genetic variants of the vitamin D receptor gene with vitiligo in a tertiary care center in a Saudi population: a case-control study.

Authors:  Ghada Bin Saif; Imran Ali Khan
Journal:  Ann Saudi Med       Date:  2022-04-07       Impact factor: 1.526

6.  Identification of underlying mechanisms and hub gene-miRNA networks of the genomic subgroups in preeclampsia development.

Authors:  Min Zhang; Xiaheng Deng; Ziyan Jiang; Zhiping Ge
Journal:  Medicine (Baltimore)       Date:  2022-07-22       Impact factor: 1.817

Review 7.  Cytokine-polymorphisms associated with Preeclampsia: A review.

Authors:  Carlos Mora-Palazuelos; Mercedes Bermúdez; Maribel Aguilar-Medina; Rosalío Ramos-Payan; Alfredo Ayala-Ham; Jose Geovanni Romero-Quintana
Journal:  Medicine (Baltimore)       Date:  2022-09-30       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.